Team:Fatih-Medical/Testpage

From 2012.igem.org

(Difference between revisions)
 
(9 intermediate revisions not shown)
Line 1: Line 1:
{{Template:Fatih-header}}
{{Template:Fatih-header}}
<html>
<html>
 +
<style>
<style>
-
#top-section { visibility: hidden; }
+
#top-section { display: none; }
-
#content {width:100%; padding:0px; }
+
#content {width:100%; padding:0px; background: none; border: none; }
-
#footer-box {visibility: hidden; height: 0px; padding: 0px; margin: 0px }
+
#footer-box { display: none; }
-
#catlinks {visibility: hidden; height: 0px; padding: 0px; margin: 0px }
+
#catlinks {display: none; }
 +
.firstHeading {display: none; }
 +
#contentSub {margin: 0px; }
 +
div#bodyContent p {margin: 0px; }
</style>
</style>
 +
<div class="bg">
<div class="bg">
Line 15: Line 20:
         <h1><a href="index.html">Fatih Medical</a></h1>
         <h1><a href="index.html">Fatih Medical</a></h1>
         <ul class="icons">
         <ul class="icons">
-
             <li><a class="normatip" title="Twitter" href="more.html"><img src="https://static.igem.org/mediawiki/2012/d/df/Fatih-Icon1.png" alt=""></a></li>
+
             <li><a class="normatip" title="Twitter" href="http://twitter.com/FatihMedical"><img src="https://static.igem.org/mediawiki/2012/d/df/Fatih-Icon1.png" alt=""></a></li>
-
             <li><a class="normatip" title="Rss" href="more.html"><img src="https://static.igem.org/mediawiki/2012/c/cb/Fatih-Icon2.png" alt=""></a></li>
+
             <li><a class="normatip" title="Fecebook" href="http://www.facebook.com/FatihMedical"><img src="https://static.igem.org/mediawiki/2012/d/d8/Fatih-Icon3.png" alt=""></a></li>
-
            <li><a class="normatip" title="Fecebook" href="more.html"><img src="https://static.igem.org/mediawiki/2012/d/d8/Fatih-Icon3.png" alt=""></a></li>
+
         </ul>
         </ul>
     <nav>
     <nav>
             <ul class="sf-menu">
             <ul class="sf-menu">
-
                 <li class="current"><a href="index.html">Home</a></li>
+
                 <li class="current"><a href="https://2012.igem.org/Team:Fatih-Medical">Home</a></li>
-
                 <li><a href="index-1.html">Team</a></li>
+
                 <li><a href="https://2012.igem.org/Team:Fatih-Medical/Team">Team</a></li>
-
                 <li><a href="index-2.html">Survey</a></li>
+
                 <li><a href="https://2012.igem.org/Team:Fatih-Medical/Anket">Anket</a></li>
-
                 <li><a href="index-3.html">Project</a></li>
+
                 <li><a href="https://2012.igem.org/Team:Fatih-Medical/Project">Project</a></li>
-
                 <li><a href="index-4.html">Parts</a></li>
+
                 <li><a href="https://2012.igem.org/Team:Fatih-Medical/Modeling">Modeling</a></li>
-
                 <li><a href="index-5.html">Modelling</a></li>
+
                 <li><a href="https://2012.igem.org/Team:Fatih-Medical/Notebook">Notebook</a></li>
-
                 <li><a href="index-5.html">Safety</a></li>              
+
                 <li><a href="https://2012.igem.org/Team:Fatih-Medical/Safety">Safety</a></li>          
             </ul>
             </ul>
             <div class="bottom"></div>
             <div class="bottom"></div>
Line 39: Line 43:
<!--==============================content================================-->
<!--==============================content================================-->
-
<section id="content">
+
<section id="content_fatih">
     <div class="container_24">
     <div class="container_24">
         <div class="wrapper">
         <div class="wrapper">
Line 45: Line 49:
         <article class="grid_8">
         <article class="grid_8">
             <div class="padding-left">
             <div class="padding-left">
-
                 <h1>CANCEL the CANCER: A SynBio Approach to the Early Diagnosis of Cancer </h1>
+
                 <h2>CANCEL the CANCER: A SynBio Approach to the Early Diagnosis of Cancer </h2>
<HR size="10" width="70%" align="left">
<HR size="10" width="70%" align="left">
Line 53: Line 57:
             <article class="grid_15">
             <article class="grid_15">
-
            <h1>About project</h1>
 
-
<BR>
 
   Our project is mainly based on the early diagnosis of cancer. EpCAM (Epithelial cell adhesion molecule) is a pan-epithelial differentiation antigen overexpressed on the basolateral surface of most carcinomas and Circulating Tumor Cells(CTC); cells which are released into blood in early phases of cancer. Our objective is to fix appropriate antibodies for EpCAM antigens to the E.coli cell wall so that we will be able to detect CTCs before the cancer precipitates its way to metastasis. For the next step, we plan to enhance the detection signal in our bacteria by the means of the quorum sensing mechanism. Finally, to prevent the production of possible undesirable and detrimental genetically modified organisms (GMOs), we aim to induce self-destruction device in our E.coli via emission of light.
   Our project is mainly based on the early diagnosis of cancer. EpCAM (Epithelial cell adhesion molecule) is a pan-epithelial differentiation antigen overexpressed on the basolateral surface of most carcinomas and Circulating Tumor Cells(CTC); cells which are released into blood in early phases of cancer. Our objective is to fix appropriate antibodies for EpCAM antigens to the E.coli cell wall so that we will be able to detect CTCs before the cancer precipitates its way to metastasis. For the next step, we plan to enhance the detection signal in our bacteria by the means of the quorum sensing mechanism. Finally, to prevent the production of possible undesirable and detrimental genetically modified organisms (GMOs), we aim to induce self-destruction device in our E.coli via emission of light.
    
    
-
<BR>
 
-
<BR>
 
-
<BR>
 
-
<BR>
 
             </article>
             </article>
Line 74: Line 72:
</div>
</div>
</div>
</div>
-
<ul id="mycarousel" class="jcarousel-skin-tango">
+
 
-
    <li><a href="more.html"><img src="images/carousel-banner1.jpg" alt=""></a></li>
+
-
    <li><a href="more.html"><img src="images/carousel-banner2.jpg" alt=""></a></li>
+
-
    <li><a href="more.html"><img src="images/carousel-banner3.jpg" alt=""></a></li>
+
-
    <li><a href="more.html"><img src="images/carousel-banner4.jpg" alt=""></a></li>
+
-
</ul>
+
<aside>
<aside>
<div class="container_24">
<div class="container_24">
Line 87: Line 80:
                     <h3>Best Services</h3>
                     <h3>Best Services</h3>
                     <ul>
                     <ul>
-
                         <li><a href="more.html">Market Research</a></li>
+
                         <li><a href="/Team:Fatih-Medical">Home</a></li>
-
                         <li><a href="more.html">Online Banking</a></li>
+
                         <li><a href="/Team:Fatih-Medical/Team">Team</a></li>
-
                         <li><a href="more.html">Financial Services</a></li>
+
                         <li><a href="/Team:Fatih-Medical/Anket">Anket</a></li>
-
                         <li><a href="more.html">Client Network Solutions</a></li>
+
                         <li><a href="/Team:Fatih-Medical/Project">Project</a></li>
-
                         <li><a href="more.html">Business Help</a></li>
+
                         <li><a href="/Team:Fatih-Medical/Parts">Parts Submitted to the Registry</a></li>
                     </ul>
                     </ul>
                 </div>
                 </div>
Line 98: Line 91:
             <h3>Popular Items</h3>
             <h3>Popular Items</h3>
                 <ul>
                 <ul>
-
                 <li><a href="more.html">Solutions &amp; Training</a></li>
+
                 <li><a href="/Team:Fatih-Medical/Modeling">Modeling</a></li>
-
                 <li><a href="more.html">Affiliate Program</a></li>
+
                 <li><a href="/Team:Fatih-Medical/Notebook">Notebook</a></li>
-
                 <li><a href="more.html">Production</a></li>
+
                 <li><a href="/Team:Fatih-Medical/Safety">Safety</a></li>
-
                 <li><a href="more.html">Risk Management</a></li>
+
                 <li><a href="/Team:Fatih-Medical/Attributions">Attributions</a></li>
-
                 <li><a href="more.html">Consultation</a></li>
+
                 <li><a href="/Team:Fatih-Medical/Survey">Survey</a></li>
                 </ul>
                 </ul>
             </article>
             </article>
Line 118: Line 111:
<div class="main">
<div class="main">
         <div class="fright"><!-- {%FOOTER_LINK} --></div>
         <div class="fright"><!-- {%FOOTER_LINK} --></div>
-
         StarCorp © 2011 &nbsp;| &nbsp;<a href="index-6.html">Privacy Policy</a>
+
         Fatih Medical © 2012 &nbsp;| &nbsp;<a href="index-6.html">Privacy Policy</a>
     </div>
     </div>
</footer>
</footer>
</body>
</body>
</html>
</html>

Latest revision as of 19:27, 11 September 2012

Fatih Medical

CANCEL the CANCER: A SynBio Approach to the Early Diagnosis of Cancer

Our project is mainly based on the early diagnosis of cancer. EpCAM (Epithelial cell adhesion molecule) is a pan-epithelial differentiation antigen overexpressed on the basolateral surface of most carcinomas and Circulating Tumor Cells(CTC); cells which are released into blood in early phases of cancer. Our objective is to fix appropriate antibodies for EpCAM antigens to the E.coli cell wall so that we will be able to detect CTCs before the cancer precipitates its way to metastasis. For the next step, we plan to enhance the detection signal in our bacteria by the means of the quorum sensing mechanism. Finally, to prevent the production of possible undesirable and detrimental genetically modified organisms (GMOs), we aim to induce self-destruction device in our E.coli via emission of light.

Retrieved from "http://2012.igem.org/Team:Fatih-Medical/Testpage"